Journal
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Volume 14, Issue 3, Pages 801-810Publisher
ELSEVIER
DOI: 10.1016/j.nano.2017.12.012
Keywords
Drug delivery; extracellular vesicles; exosomes; flow cytometry; nanomedicine; nanoparticles
Funding
- Cancer-ID program [HLT02]
- MEMPHISII program of the Netherlands Technology Foundation STW [HLT02]
- European Metrology Research Programme (EMRP) [HLT02]
- EMRP participating countries within the European Association of National Metrology Institutes
- European Union
Ask authors/readers for more resources
Blood contains extracellular vesicles (EVs), which are biological nanoparticles with clinical applications. In blood plasma, EVs are outnumbered by similar-sized lipoprotein particles (LPs), leading to controversial data such as non-specific binding of antibodies to LPs. Flow cytometry is a clinically applicable technique to characterize single EVs in body fluids. However, flow cytometry data have arbitrary units, impeding standardization, data comparison, and data interpretation, such as differentiation between EVs and LPs. Here we present a new method, named flow cytometry scatter ratio (Flow-SR), to relate the ambiguous light scattering signals of flow cytometry to the diameter and refractive index (RI) of single nanoparticles between 200-500 nm in diameter. Flow-SR enables label-free differentiation between EVs and LPs and improves data interpretation and comparison. Because Flow-SR is easy to implement, widely applicable, and more accurate and faster than existing techniques to size nanoparticles in suspension, Flow-SR has numerous applications in nanomedicine. (c) 2018 The Authors. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available